Performance status score: do patients and their oncologists agree?
about
Order effects: a randomised study of three major cancer-specific quality of life instruments.Moving beyond Karnofsky and ECOG Performance Status Assessments with New TechnologiesPemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)A case report of local treatment of inoperable squamous cell lung carcinoma with convex-probe endobronchial ultrasound-guided intratumoral injection of cisplatin in a patient with severe COPD.Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.Changes in daily activities of cancer patients after diagnosis: how do canadian and Iranian patients perceive the change?Using claims-based measures to predict performance status score in patients with lung cancerMapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population.Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.Risk of Ovarian Cancer Relapse score: a prognostic algorithm to predict relapse following treatment for advanced ovarian cancer.Maintenance therapy in advanced non-small cell lung cancer: evolution, tolerability and outcomes.Geriatric assessment-identified deficits in older cancer patients with normal performance status.Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic.Second-line treatment of stage III/IV non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice: evaluation of performance status and health-related quality of life.Research methodology: cancer cachexia syndrome.The Danish Neuro-Oncology Registry: establishment, completeness and validity.Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?Discrepancy in patient-rated and oncologist-rated performance status on depression and anxiety in cancer: a prospective study protocolValidation of the English and Chinese versions of the Quick-FLIC quality of life questionnaire.Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer PatientsAn inflammation based score can optimize the selection of patients with advanced cancer considered for early phase clinical trials.Inflammation as a validated prognostic determinant in carcinoma of unknown primary siteAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.Effect of brief psychoeducation using a tablet PC on distress and quality of life in cancer patients undergoing chemotherapy: a pilot study.Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature.Validation Study for the Brief Measure of Quality of Life and Quality of Care: A Questionnaire for the National Random Sampling Hospital Survey.How Do Hospital Palliative Care Teams Use the WHO Guidelines to Manage Unrelieved Cancer Pain? A 1-Year, Multicenter Audit in Japan.Variability of performance status assessment between patients with hematologic malignancies and their physicians.Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies.Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients.Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases.Dysfunctional remembered parenting in oncology outpatients affects psychological distress symptoms in a gender-specific manner.Provider impact on survival outcomes in the management of malignant disease.Psychometric Analysis of the Parenting Concerns Questionnaire in Women With Metastatic Cancer.Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?Patient-reported outcomes are associated with patient-oncologist agreement of performance status in a multi-ethnic Asian population.The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.A methodology to extract outcomes from routine healthcare data for patients with locally advanced non-small cell lung cancer.The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China.
P2860
Q24811022-3954558E-79C0-4A6A-AEDD-5E456455DD2DQ26749492-5801C385-B711-4B69-917C-6DF54094695FQ28081243-05EC44CE-CAF4-4E1C-9584-2EA4A302EA00Q33818023-DBA41FC9-4432-4AEB-8648-F6F186E6C3A0Q33946233-8BC023EE-3687-4C75-96B0-BC6476207CA9Q34082514-A3D5D6A9-A490-48DC-8038-97D400CC4437Q34609460-35C26CF0-AD20-4889-9C90-F64F750D0FE9Q34707998-38547362-02CE-4889-BE16-31DA6FA09B07Q35104573-9C4B6188-D2C0-484A-A995-37A04DA00240Q35121862-E244ECAF-1C80-4DDE-A69A-0C923142A1F9Q35146923-E858D156-74CB-45CA-9CAB-22E04DAAEDA1Q35345579-62F5A8C3-0F00-4AD3-BAB6-57DCED90A686Q35559782-43370176-5EB0-434E-BE30-FFE0D53DFF0CQ35802325-8EBAC6FC-5549-4458-91F6-BBBE98561BFCQ35872798-733FFF59-A503-4CF1-91C3-AC9B1B86BECFQ36117342-B127838C-F470-47BD-8224-37AD38174908Q36127240-779987FD-5EF2-4CA3-B508-6272A31D4AD3Q36370378-E648BC4A-A871-4093-8A7D-818AA8C62A57Q36616280-0509BCAA-B168-4079-85F9-2493882D3B74Q36632375-1C7CD72C-DCBF-46E3-95AB-72DE4EF71208Q37197157-7B175802-B9AA-407B-94BE-71436262EA62Q37444815-BE3239A0-BBBB-410C-9290-E9C39DC5AD1EQ37459607-80ADF09A-A1D2-4321-9DF8-69E84F4515ADQ37960818-F7389DCD-450A-46A8-8B59-5B1EFB176728Q38441322-1BEC4EA2-792E-4B55-BBB4-82FBDC85706CQ38523355-ED76634E-79CC-407A-9262-9E46F8DE43E5Q38920504-8D93E41B-B38B-4381-8DB3-A41E45339C0EQ39182361-983B2726-5629-45AA-9528-4FB6205EFFBAQ40118890-0131D980-C5B1-451C-880E-349E911C82C8Q40610972-8A2DDFF9-4527-400F-B740-B5FA58684254Q45268899-272CBC79-0CC5-4BB0-B315-B70C55266774Q47196378-94222EEC-6DAD-4025-9011-F02A67DBE203Q47563876-8972C8F8-4FEB-408F-8AE1-4D1FEEF1F196Q47638292-FC90A35E-B14E-42D4-97D4-421976A9BA31Q47679676-87E5474D-FB1D-4B52-9C9F-C2B110E7C0C9Q47869630-A129110B-098F-44B7-B68E-7889D5161574Q48071799-1D0FFED2-0929-499B-A175-44AD9DC9752AQ48432977-ED355D65-34BB-4C16-9705-F672BBEBB322Q52593429-2A0BF8FA-9416-4B5C-9C0C-94E14174DF63Q54403606-3D044053-3A41-4EB8-AC8A-562B77E33BD6
P2860
Performance status score: do patients and their oncologists agree?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Performance status score: do patients and their oncologists agree?
@ast
Performance status score: do patients and their oncologists agree?
@en
type
label
Performance status score: do patients and their oncologists agree?
@ast
Performance status score: do patients and their oncologists agree?
@en
prefLabel
Performance status score: do patients and their oncologists agree?
@ast
Performance status score: do patients and their oncologists agree?
@en
P2093
P2860
P356
P1476
Performance status score: do patients and their oncologists agree?
@en
P2093
D Gilligan
L D Sharples
L R A Magee
S C Charman
S P Blagden
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601231
P407
P577
2003-09-01T00:00:00Z